Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Lithio

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Cancer|October 27, 2020
Phase 1 study to evaluate Crenigacestat (LY3039478) in combination with dexamethasone in patients with T-cell acute lymphoblastic leukemia and lymphomaGautam Borthakur, Giovanni Martinelli, Emmanuel Raffoux, et al.
Plant Physiology|December 22, 2016
Stability of Single-Parent Gene Expression Complementation in Maize Hybrids upon Water Deficit StressCaroline Marcon, Anja Paschold, Waqas Ahmed Malik, et al.
Frontiers in Oncology|March 27, 2025
Abemaciclib in combination with therapies for patients with metastatic breast cancer: a phase 1b studySara M Tolaney, Komal Jhaveri, Teresa Helsten, et al.
Investigational New Drugs|January 22, 2021
Aurora kinase A inhibitor, LY3295668 erbumine: a phase 1 monotherapy safety study in patients with locally advanced or metastatic solid tumorsQuincy Siu-Chung Chu, Nathaniel Bouganim, Caroline Fortier, et al.
Frontiers in Oncology|February 28, 2022
Abemaciclib in Combination With Endocrine Therapy for Patients With Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: A Phase 1b StudySara M Tolaney, Muralidhar Beeram, J Thaddeus Beck, et al.
The Lancet. Oncology|October 30, 2025
Abemaciclib plus abiraterone in patients with metastatic castration-resistant prostate cancer (CYCLONE 2): a randomised, double-blind, placebo-controlled, phase 3 trialMatthew Smith, Josep Piulats, Tilman Todenhöfer, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Cancer|October 27, 2020
Phase 1 study to evaluate Crenigacestat (LY3039478) in combination with dexamethasone in patients with T-cell acute lymphoblastic leukemia and lymphomaGautam Borthakur, Giovanni Martinelli, Emmanuel Raffoux, et al.
Plant Physiology|December 22, 2016
Stability of Single-Parent Gene Expression Complementation in Maize Hybrids upon Water Deficit StressCaroline Marcon, Anja Paschold, Waqas Ahmed Malik, et al.
Frontiers in Oncology|March 27, 2025
Abemaciclib in combination with therapies for patients with metastatic breast cancer: a phase 1b studySara M Tolaney, Komal Jhaveri, Teresa Helsten, et al.
Investigational New Drugs|January 22, 2021
Aurora kinase A inhibitor, LY3295668 erbumine: a phase 1 monotherapy safety study in patients with locally advanced or metastatic solid tumorsQuincy Siu-Chung Chu, Nathaniel Bouganim, Caroline Fortier, et al.
Frontiers in Oncology|February 28, 2022
Abemaciclib in Combination With Endocrine Therapy for Patients With Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: A Phase 1b StudySara M Tolaney, Muralidhar Beeram, J Thaddeus Beck, et al.
The Lancet. Oncology|October 30, 2025
Abemaciclib plus abiraterone in patients with metastatic castration-resistant prostate cancer (CYCLONE 2): a randomised, double-blind, placebo-controlled, phase 3 trialMatthew Smith, Josep Piulats, Tilman Todenhöfer, et al.
Pageof 2